Cadherin-11 and cardiac fibrosis: A common target for a common pathology

Area of Science:

• Cardiology
• Cell Biology
• Biomedical Engineering

Background:

• Cardiac fibrosis is a key factor in cardiovascular diseases, the leading global cause of death.
• Fibrosis involves fibroblast activation into myofibroblasts, excessive extracellular matrix deposition, persistent inflammation, and cellular responses to mechanical stress.

Purpose of the Study:

• To review the mechanisms driving cardiac fibrosis in cardiovascular diseases.
• To explore cadherin-11 as a potential therapeutic target linking fibrotic, inflammatory, and biomechanical pathways.

Main Methods:

• Literature review of pro-fibrotic, pro-inflammatory, and biomechanical mechanisms in cardiac fibrosis.
• Analysis of cadherin-11's role as an intercellular adhesion protein in myofibroblasts and inflammatory cells.

Main Results:

• Cardiac fibrosis results from complex interactions between pro-fibrotic, pro-inflammatory, and biomechanical factors.
• Cadherin-11 is identified as a potential unifying factor in these fibrotic mechanisms.
• Blocking cadherin-11 dimerization has shown promise in preventing fibrotic diseases, including cardiac fibrosis.

Conclusions:

• Understanding cadherin-11's role is crucial for developing novel therapeutic interventions for cardiac fibrosis.
• Targeting cadherin-11 offers a potential strategy to treat cardiovascular diseases characterized by fibrosis.